Found: 6
Select item for more details and to access through your institution.
A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case series.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 2, p. 162, doi. 10.1177/1756283X15622779
- By:
- Publication type:
- Article
Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series.
- Published in:
- JOP Journal of the Pancreas, 2014, v. 15, n. 1, p. 38
- By:
- Publication type:
- Article
Ototoxicity Associated with Oxaliplatin in a Patient with Pancreatic Cancer.
- Published in:
- JOP Journal of the Pancreas, 2013, v. 14, n. 6, p. 676
- By:
- Publication type:
- Article
A Retrospective Study of Capecitabine/Temozolomide (CAPTEM) Regimen in the Treatment of Metastatic Pancreatic Neuroendocrine Tumors (pNETs) after Failing Previous Therapy.
- Published in:
- JOP Journal of the Pancreas, 2013, v. 14, n. 5, p. 498
- By:
- Publication type:
- Article
Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma.
- Published in:
- Oncology Letters, 2014, v. 8, n. 3, p. 1302, doi. 10.3892/ol.2014.2238
- By:
- Publication type:
- Article